Tuesday, June 18, 2013

Mirabilis Medica Gets $7M In Series A-1

Bothell-based Mirabilis Medica, a developer of ultrasound technology aimed at treating uterine fibroids, said Monday that i thas raised $7M in a Series A-1 funding, part of an ongoing $13M funding round. The funding was led by GSR Ventures, and also included Charter Life Sciences. Mirabilis said the new funding included both $4M in cash and $3M in conversion of notes to equity. Mirabilis Medica said the funding will go towards research and development of its technology.